Members of the Quest Diagnostics senior management team today presented the company’s new two-point strategy to analysts and investors at its Investor Day in New York City.

“Quest Diagnostics is laser-focused on accelerating growth and driving operational excellence to continue building shareholder value,” Quest President and Chief Executive Officer Steve Rusckowski said in a statement. “Our increasing number of partnerships with other health care leaders are creating promising opportunities for top and bottom line growth while improving the patient experience and reducing the overall cost of care.”

Prior to the Investor Day meeting, Quest announced a raised outlook for revenue growth for the period 2017-2020. More detailed information can be found in this press release.

A webcast of the Investor Day event is available on Quest’s Investor Relations site.